Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-056916
Filing Date
2025-06-05
Accepted
2025-06-05 17:23:04
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2514537d3_s1a.htm S-1/A 606148
2 EXHIBIT 5.1 tm2514537d3_ex5-1.htm EX-5.1 13253
3 EXHIBIT 23.1 tm2514537d3_ex23-1.htm EX-23.1 3535
4 EXHIBIT 23.2 tm2514537d3_ex23-2.htm EX-23.2 3383
5 GRAPHIC tm2512534d1_drsimg001.jpg GRAPHIC 4367
6 GRAPHIC tm2514537d1_ex23-2img01.jpg GRAPHIC 2326
7 GRAPHIC tm2514537d1_ex23-2img02.jpg GRAPHIC 4405
8 GRAPHIC tm2514537d1_ex23-2img03.jpg GRAPHIC 2493
9 GRAPHIC tm2514537d1_ex5-1img01.jpg GRAPHIC 11845
  Complete submission text file 0001104659-25-056916.txt   663507
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-287185 | Film No.: 251028227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)